-
HEALTH-RELATED QUALITY OF LIFE IN HEART FAILURE IN SAUDI ARABIA: A COMPARATIVE ASSESSMENT USING THE EQ-5D-5L AND EQ-HWB-9
Aug 11, 2026, 17:16 PM -
EQ-5D-5L-DERIVED UTILITY DRIVERS OF HRQOL IN HAE AND COMPARISON WITH PATIENT REPORTED QUALITATIVE FINDINGS
Aug 11, 2026, 17:16 PM -
CHARACTERIZING PEOPLE WITH UNTREATED MULTIPLE SCLEROSIS IN REAL-WORLD EVIDENCE: INSIGHTS FROM LITERATURE AND THE GERMAN NEUROTRANSDATA REGISTRY (2018-2024)
Aug 11, 2026, 17:16 PM -
EMPIRICAL ECONOMIC EVALUATION AND ENVIRONMENTAL IMPACT ASSESSMENT OF REUSABLE VERSUS SINGLE-USE CATHETERS FOR CLEAN INTERMITTENT CATHETERISATION
Aug 11, 2026, 17:16 PM -
BEYOND EXPECTED OUTCOMES: A FRAMEWORK TO ACCOUNT RISK AVERSION WHEN ELICITING PATIENT PREFERENCES FOR TREATMENT PATHWAYS IN ONCOLOGY
Aug 11, 2026, 17:16 PM -
A DIALYSIS-REVEALED WILLINGNESS-TO-PAY THRESHOLD FOR END-STAGE RENAL DISEASE: COST-UTILITY OF TRANSPLANTATION VERSUS DIALYSIS IN MOROCCO
Aug 11, 2026, 17:16 PM -
MOST-FAVORED-NATION DRUG PRICING AND REFERENCE-PRICING VULNERABILITY ACROSS THE MIDDLE EAST AND NORTH AFRICA: A STRUCTURAL TYPOLOGY
Aug 11, 2026, 17:16 PM -
INDIRECT TREATMENT COMPARISONS (ITCS) IN THE EUROPEAN HTA CONTEXT: CRITICAL ANALYSIS OF THE FIRST JOINT CLINICAL ASSESSMENT REPORT ON TOVORAFENIB AND COMPARISON WITH G-BA AND HAS
Aug 11, 2026, 17:16 PM -
CALCULATING THE REAL-WORLD INCREMENTAL COST-EFFECTIVENESS RATIO FOR DARATUMUMAB WITH LENALIDOMIDE AND DEXAMETHASONE IN THE SECOND-LINE SETTING FOR RELAPSED REFRACTORY MYELOMA IN BRITISH COLUMBIA
Aug 11, 2026, 17:16 PM -
ANTIMICROBIAL STEWARDSHIP EVALUATION OF NEWLY INTRODUCED ANTIBIOTICS IN JORDANIAN HOSPITALS
Aug 11, 2026, 17:16 PM -
THE EVOLVING ACCESS AND POLICY CONCERNS OF GLOBAL PHARMACEUTICAL MANUFACTURERS: AN ANALYSIS OF CHALLENGES AND POLICY SOLUTIONS IDENTIFIED IN MANUFACTURERS' COMMENTS IN RESPONSE TO INTERNATIONAL REFERENCE PRICE-BASED PROPOSALS
Aug 11, 2026, 17:16 PM -
REAL WORLD IMPACT OF LONG ACTING INJECTABLE ANTIPSYCHOTICS ON HEALTHCARE UTILIZATION AND COSTS IN PATIENTS WITH PSYCHOTIC DISORDERS AND INTELLECTUAL DISABILITY IN PORTUGAL
Aug 11, 2026, 17:16 PM -
INSIGHTS FROM A NATIONAL CANCER REGISTRY: CLINICAL CHARACTERISTICS AND TREATMENT PATHWAYS OF METASTATIC BREAST CANCER PATIENTS IN GERMANY - A RETROSPECTIVE ANALYSIS OF ZFKD DATA
Aug 11, 2026, 17:16 PM -
COMPARISON OF SIMULATED TREATMENT COMPARISON AND MATCHING-ADJUSTED INDIRECT COMPARISON FOR LONGITUDINAL BINARY OUTCOMES WITH LOW POPULATION OVERLAP
Aug 11, 2026, 17:16 PM -
VACTS-PSO: A PAYER-ORIENTED VALUE FRAMEWORK INTEGRATING CLINICAL OUTCOMES, QUALITY OF LIFE, AND REAL-WORLD INTENSIFICATION COSTS IN PSORIASIS
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF BLADDER-PRESERVING TREATMENT VERSUS RADICAL CYSTECTOMY IN MUSCLE-INVASIVE BLADDER CANCER: A DUTCH REAL-WORLD HEALTH ECONOMIC ANALYSIS
Aug 11, 2026, 17:16 PM -
THE SENSITIVITY ANALYSIS PARADOX IN TARGET TRIAL EMULATION: AN EMPIRICAL TAXONOMY OF BIAS MITIGATION AND PROTOCOL DESIGN IN 208 STUDIES
Aug 11, 2026, 17:16 PM -
ECONOMIC BURDEN OF CHRONIC SPONTANEOUS URTICARIA IN BULGARIA: A COST-OF-ILLNESS ANALYSIS
Aug 11, 2026, 17:16 PM -
CAPTURING REAL-WORLD PATIENT EXPERIENCE: CROSS-INDICATION VALIDATION OF AN LLM SOCIAL MEDIA LISTENING PIPELINE WITHOUT RETRAINING
Aug 11, 2026, 17:16 PM -
OPERATIONALIZING RESPONSIBLE AI USE IN SYSTEMATIC LITERATURE REVIEWS: DEVELOPING A RISK-BASED WORKFLOW
Aug 11, 2026, 17:16 PM
